Certified by Founder Lodge
En Carta Diagnostics
France - Paris
START UP
1 Disclosed Funding Rounds $1,623,697
0 Participating Investments
-
Founded date
2022
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Diagnostics for Better care, Everywhere.
En Carta Diagnostics is a synthetic-biology biotech company leveraging patented technologies to decentralise highly reliable molecular diagnostic s
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| May, 23 ,2024 | Pre-Seed | $1,623,697 |
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Katalist | $1,500,000 | (Dec 19, 2025)
Amphix Bio | $12,500,000 | (Dec 19, 2025)
Neural Concept | $100,000,000 | (Dec 19, 2025)
Gravity Labs Co., Ltd. | $17,000,000 | (Dec 19, 2025)
arcads AI | $16,000,000 | (Dec 19, 2025)
